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Abstract
Background: b-adrenoceptor activation in the hippocampus is sufficient to
induce heterosynaptic long-term potentiation of perforant path input to the
dentate gyrus. However, in vitro and in vivo studies suggest the plasticity effects
of b-adrenoceptor activation may vary depending on the level of receptor acti-
vation. Methods: The present experiments use an in vivo model concurrently
infusing differing concentrations of the b-adrenoceptor agonist, isoproterenol
(ISO; 0, 0.1, 1, 10, and 100 lmol/L in aCSF; 1 lL over 12.5 min) in the dentate
gyrus, while monitoring changes in the perforant path-evoked potential at the
same site. Results: Long-term depression (LTD) of fEPSP slope was elicited by
0.1 lmol/L ISO. Higher doses did not alter fEPSP slope. Maximal long-term
potentiation of the perforant path-evoked population spike (183% >3 h)
occurred at 10 lmol/L ISO. Transient depression of spike amplitude occurred
at 0.1 lmol/L ISO. Conclusions: These data demonstrate concentration-depen-
dent effects of b-adrenoceptor activation on the perforant path-evoked poten-
tial. Long-term depression and long-term potentiation of perforant path-evoked
responses are variably elicited as a function of the degree of receptor activation.
Introduction
The electrophysiological effects of b-adrenergic activation
on perforant path-evoked potentials in the dentate gyrus
have been studied extensively in vitro using the b-
adrenergic receptor agonist isoproterenol (ISO) (Lacaille
and Harley 1985; Dahl and Sarvey 1990; Dahl and Li
1994a), but to date no in vivo recordings with infused
ISO have been attempted. This study addresses this issue
and characterizes a spectrum of dose–response effects of
ISO on both the dentate gyrus—perforant path-evoked
field excitatory postsynaptic field potential (fEPSP) slope
and population spike.
Previous in vivo studies indicate that b-adrenergic
receptor-dependent activation in the dentate gyrus reli-
ably recruits potentiation of the perforant path popula-
tion spike (Harley and Milway 1986; Harley et al. 1989;
Washburn and Moises 1989; Kitchigina et al. 1997;
Chaulk and Harley 1998; Walling and Harley 2004; Wall-
ing et al. 2004; Knight and Harley 2006), while effects on
fEPSP slope are more variable with both potentiation or
mixed effects including potentiation and depression (Har-
ley and Milway 1986; Chaulk and Harley 1998) or no
changes (Washburn and Moises 1989; Walling and Harley
2004; Walling et al. 2004) being reported.
In vitro fEPSP slope potentiation (Lacaille and Harley
1985; Dahl and Sarvey 1989; Pelletier et al. 1994) and
population spike potentiation (Lacaille and Harley 1985;
Stanton and Sarvey 1985; Dahl and Sarvey 1989; Burgard
and Sarvey 1991; Dahl and Li 1994a) have been observed
with b-adrenoceptor activation, but population spike
potentiation is again the more robust of the two effects
(Lacaille and Harley 1985; Dahl and Li 1994a,b).
With in vitro activation of b-adrenergic activation
receptors there is a threshold (~1 lmol/L ISO) for the
occurrence of long-term potentiation (Dahl et al. 1990;
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Dahl and Li 1994a). In vivo there is also a critical thresh-
old for the long-term population spike potentiation
effects using norepinephrine as an activator (estimated
synaptic concentration of ~3 lmol/L) with lower concen-
trations producing shorter term potentiation (Harley
et al. 1996).
Here, four concentrations of the b-adrenergic receptor
agonist ISO, and a vehicle (aCSF) control were infused
adjacent to a recording electrode in the dentate gyrus of
the hippocampus in urethane-anesthetized rats. Evoked
potentials elicited by single pulse stimulation of the perfo-
rant path every 30 sec probed the magnitude of the per-
forant path fEPSP and the population spike. Evoked
potential changes elicited by a 12 min infusion period
were followed for 3 h.
Material and Methods
Subjects
Male Sprague-Dawley rats (250–400 g; Memorial Univer-
sity of Newfoundland) were used. Rats were housed
under a 12:12 h light condition (lights on at 08:00 h) and
fed regular rat chow and water ad libitum. All procedures
were conducted in accordance with the Canadian Council
on Animal Care specifications, and were authorized by
the Memorial University Institutional Animal Care Com-
mittee.
Surgery
Rats were anesthetized with urethane (1.5 g/kg, i.p.) and
placed in a stereotaxic instrument in the skull flat position
and body temperature was monitored and maintained at
37°C by a thermoregulated heating pad (FHC, Bowdoin,
ME). Electrode placements were mapped according to the
coordinates found in the Paxinos and Watson brain atlas
(Paxinos and Watson 1998) for the perforant path
(7.2 mm posterior and 4.1 mm lateral from bregma) and
for dentate gyrus (3.5 mm posterior and 2.0 mm lateral).
A concentric bipolar stimulating electrode (NE-100; Kopf
Instruments, Tujanga, CA) was lowered into the perforant
path (~3.0 mm from brain surface). A conjoined elec-
trode/cannula assembly was constructed of a single stain-
less steel recording electrode (0.5–1 MΩ; FHC Inc.) and a
22-gauge stainless steel guide cannula (Plastics One, Roa-
noke, VA). The cannula and electrode, secured together
with regular epoxy, were aligned so that a 28 gauge injec-
tion cannula, when inserted into the guide cannula would
sit, ~25 lm lateral and 50 lm dorsal to the tip of the elec-
trode. This ensured that the concentration delivered at the
recording site was as close as possible to the concentration
infused. The internal injection cannula (Plastics One) was
attached to a solution-filled (ISO in aCSF or aCSF only)
autoanalyzer tubing and a dH2O-filled 5 lL microsyringe.
The total injection (guide and internal cannula) and
recording assembly was then slowly lowered into the gran-
ule cell layer of the dentate gyrus (~2.5–3.5 mm from
brain surface). The electrode placement was localized to
the granule cell layer by monitoring the response to
0.2 ms test pulses delivered to the perforant path and by
maximizing the positive-going fEPSP and negative-going
population spike.
Stimulation and recording procedures
Single monophasic square wave test pulses (0.2 ms) were
delivered to the perforant path using an interstimulus
interval of 30 sec (Neurodata Instruments, New York,
NY). The evoked responses were amplified, filtered
(0.3 Hz to 3 kHz; P5-11; Grass Instruments, West War-
wick, RI), and digitized at a rate of 10 kHz and stored
online for analysis.
At the commencement, and at the termination of the
recording period, an input–output current intensity series
(I/O curve) was determined. This consisted of sampling
three evoked responses at interstimulus intervals (ISI) of
10 sec, at each current level from 100 to 1000 lA at
100 lA intervals. On the basis of the initial I/O curve, a
current intensity for baseline current stimulation was cho-
sen at the intensity that produced approximately 50% of
the maximal population spike.
DataWave software (DataWave Technologies; Loveland,
CO) was used to collect waveforms and analysis was
performed after the experiments (see Data Analysis and
Statistics). Baseline-evoked responses were recorded every
30 sec for at least 1 h before ISO infusion began.
Procedures for isoproterenol infusion
The drug for infusion, l-isoproterenol (Sigma, St. Louis,
MO), was made up to four different concentrations (0.1,
1, 10, and 100 lmol/L) in aCSF and kept frozen until use.
The solutions were delivered through an electrical syringe
pump (Instech, Plymouth Meeting, PA) calibrated to deli-
ver a total volume of 1 lL over 12.5 min. The experiment
consisted of a baseline recording (1 h) and an infusion
period, after which evoked responses were recorded for an
additional 3 h following termination of infusion.
Histological assessment of placements, and
data analysis
Upon termination of recording, anesthetized animals were
decapitated and the brains were removed quickly and
frozen for cryostat sectioning. Coronal sections (30 lm)
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were taken and electrode placements were visualized using
cresyl violet staining and glycogen phosphorylase histo-
chemistry, as described by Walling et al. (2007). Animals
in which electrode or cannula placement occurred outside
the dentate gyrus were excluded from analysis.
DataWave software was used to measure the popula-
tion spike amplitude (first positive peak  first valley)
and fEPSP slope (ΔV/Δt) for each waveform recorded.
The average value for the last 30 min of baseline record-
ing was used to evaluate changes in both population spike
amplitude and fEPSP slope for the duration of recording.
Measurements were normalized to the mean of the popu-
lation spike amplitude or fEPSP slope measurement for
the 30-min period prior to infusion onset and trans-
formed into 5-min means.
Within-group analyses
Repeated measures analysis of variance (ANOVA) was
used to evaluate the effects of intrahippocampal applica-
tion of ISO on population spike amplitude and fEPSP
slope at each of the concentrations (aCSF, 0.1, 1, 10,
100 lmol/L 9 time). If significant effects were found,
further post hoc analyses were carried out using Fisher’s
test for Least Significant Differences (LSD) to characterize
the differences. Effects were considered significant if the
5-min means after the start of the infusion were signifi-
cant (P < 0.05) from all (6) 5-min means in the 30-min
baseline period. A minimum of two consecutive mean
calculations were required to be statistically different from
baseline. Significance was set at P < 0.05.
Between-group analyses
Two-way repeated measures ANOVAs (groups: aCSF, 0.1,
1, 10, 100 lmol/L 9 times: 15 min preinfusion and 15,
110, and 180 min postinfusion) were used to assess differ-
ences in the effects among varying concentrations of ISO.
Again, LSD analysis was employed when the interaction
was found to be significant and the criteria level was set
at a minimum of P < 0.05.
Correlations and input/output curves
Pearson product–moment correlations were calculated
across all animals in each group for the natural variations
in slope–spike relationships at the same time points ana-
lyzed in the between-group tests (15 min preinfusion and
15, 110, and 180 min postinfusion). A two-tailed test of
significance (P < 0.05) was employed. At the conclusion
of each experiment (180 min), a second input/output
curve was obtained and the results graphed relative to
predrug data.
Results
Histological analysis confirmed correct electrode/cannula
placement in 31 rats: 0.1 lmol/L ISO = 6, 1 lmol/L
ISO = 6, 10 lmol/L ISO = 6, 100 lmol/L ISO = 6 and
aCSF = 7. The mean of the population spike and the
EPSP slope during the 30-min baseline period did not
differ between groups and so are reported en totale. The
mean population spike amplitude and the mean EPSP
slope measurement for the 30-min baseline period prior
to ISO infusion were 3.52  1.53 mV and 4.12 
1.9 mV/ms, respectively.
Concentration-dependent effects of
intrahippocampal isoproterenol on the
perforant path-evoked fEPSP slope
The within-group analysis of the evoked fEPSP slope
measurements revealed that only a single concentration of
ISO produced long-term effects on the perforant path-
evoked fEPSP response. Infusion of 0.1 lmol/L ISO pro-
duced a large and persistent depression of fEPSP slope
(F41,205 = 11.746; P < 0.00001; n = 6; see Fig. 1B). The
onset of depression began during the infusion and per-
sisted for the 3-h recording period postinfusion, although
diminishing over time. The largest mean decrease, 51% of
baseline EPSP slope, occurred 10 min after infusion
onset.
Although 1 lmol/L ISO also appeared to produce a
small depression of the fEPSP slope, this effect was not
significant (F41,205 = 0.49; P < 0.996; n = 6; see Fig. 1C).
Infusion of aCSF vehicle (Fig. 1A) or other ISO concen-
trations (10 and 100 lmol/L; Fig. 1D–E) also failed to
alter the evoked fEPSP slope.
Between-group analyses of the varying concentrations
of ISO revealed a significant interaction (F12,78 = 2.5756;
P < 0.006; see Fig. 1F). At 15 min postinfusion, the
fEPSP slope of rats receiving 0.1 lmol/L ISO was lower
than that observed after any other concentration or
aCSF vehicle. By 110 min postinfusion, the fEPSP slope
of the 0.1 lmol/L ISO group was still lower than the
aCSF and 10 lmol/L ISO groups. Although the pattern
of group differences remained similar, by 180 min
postinfusion, no differences in fEPSP slope were found
among groups.
Concentration-dependent effects of
intrahippocampal isoproterenol on the
perforant path-evoked population spike
Graphed data for the intrahippocampal infusions of four
concentrations (0.1, 1, 10, and 100 lmol/L) of ISO and
the aCSF vehicle on the dentate gyrus evoked population
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(A) (B)
(C) (D)
(E)
(F)
Figure 1. Intrahippocampal infusion of the lowest dose ISO produces a robust b-adrenergic receptor-dependent long-term potentiation (LTP) of
the perforant path-dentate gyrus fEPSP slope in anesthetized rats. (A) Infusion of vehicle (aCSF; n = 7) did not alter the evoked EPSP slope
measurement from baseline levels (B) Infusion of the lowest concentration of ISO (0.1 lmol/L) produced a robust, and enduring (>3 h) depression
of the fEPSP slope from measurement of the preinfusion (baseline) period. (C–E) Infusion of all other concentrations of ISO (1, 10, and 100 lmol/
L) did not significantly alter the fEPSP slope measurement from that of baseline recording. (F) Comparative examination of the effects of
intrahippocampal infusion of the varying concentrations of ISO on the perforant path-dentate gyrus EPSP during the recording period. There was
a significant concentration 9 time interaction (F12,78 = 2.5756; P < 0.006). Post hoc analyses revealed that at 15 min postinfusion the lowest ISO
concentration (0.1 lmol/L) decreased EPSP slope measurement from vehicle (aCSF)-infused control rats and was also decreased compared to
groups infused with all other concentrations of ISO (1, 10, and 100 lmol/L). By 110 min postinfusion the depression of the EPSP slope of the
0.1 lmol/L ISO group was only different from the aCSF group and the 10 lmol/L ISO group. By 180 min postinfusion, no between-group
differences in fEPSP slope measurements were observed. Vehicle (aCSF) data are included in all graphs for comparative purposes. Solid bar
indicates time and duration of infusion. All data represent means and standard error of the mean. * represents differences in minimum P < 0.05
from baseline measurements. See Figure 2 for sample waveforms.
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(A) (B)
(C) (D)
(E) (F)
Figure 2. Intrahippocampal infusion of ISO produces a b-adrenergic receptor-dependent long-term potentiation (LTP) of the perforant path-
dentate gyrus evoked population spike consistent with an inverted dose–response U-curve. (A) Intrahippocampal infusion of vehicle (aCSF) did not
alter the population spike amplitude. (B) Infusion of the lowest concentration (0.1 lmol/L) ISO produced a transient population spike depression.
(C–E) Infusion of higher concentrations of ISO produced potentiation of the perforant path-dentate gyrus population spike. Potentiation was most
robust and enduring after infusion of 10 lmol/L ISO (D), while potentiation after infusions of 1 lmol/L (C) or 100 lmol/L (E) ISO were delayed or
fluctuated throughout the recording period. (F) Between-group analysis demonstrated a significant concentration 9 time interaction
(F12,78 = 2.4123; P < 0.01). Post hoc assessment revealed that 15 min postinfusion there was a significant depression of the population spike
amplitude in rats in the 0.1 lmol/L group compared to rats in the aCSF infused control group. Furthermore, rats receiving 10 lmol/L ISO
infusions had increases in spike amplitude exceeding that of all other groups. This effect on spike amplitude persisted at 110 min, but by 180 min
postinfusion the spike amplitude increases in the 10 lmol/L group was only elevated over aCSF- and 100 lmol/L ISO infused rats. Insets:
representative waveforms of rats infused with ISO 30 min preinfusion (solid line), and 180 min post (dashed line) infusion. Vehicle (aCSF) data are
included in all graphs for comparative purposes. Solid bar indicates time and duration of infusion. Scale bar represents 2 mV and 2 ms. All data
represent means and standard error of the mean. * represents differences in minimum P < 0.05 from baseline measurements.
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spike are presented in Figure 2. Infusion of the aCSF
vehicle (n = 7) did not alter the amplitude of the evoked
population spike (Fig. 2A).
Repeated measures analysis of the effects within each
group revealed a concentration-dependent effect on the
evoked population spike. First, infusion of the lowest con-
centration of ISO, 0.1 lmol/L (n = 6) produced a tran-
sient depression of the dentate gyrus evoked population
spike from baseline responses (F41,205 = 1.555, P < 0.025;
see Fig. 2B). Post hoc analysis revealed that this decrease
began at the termination of infusion and was maximal at
46% of the baseline spike amplitude. The depression
lasted for four 5-min samples (20 min) and then returned
to baseline.
The remaining concentrations of intrahippocampal ISO
(1, 10, and 100 lmol/L) produced a potentiation of the
perforant path—dentate gyrus evoked population spike
(see Fig. 2C–E). The potentiation observed at the 1 lmol/
L concentration (F41,205 = 3.3424; P < 0.0001; n = 6)
began following infusion termination and was signifi-
cantly different ~75 min later with a maximal mean
potentiation from baseline of 133%. The response
returned to baseline before 3 h of recording had elapsed.
Application of ISO at 10 lmol/L concentration produced
the largest and most enduring increases in population
spike amplitude (F41,205 = 4.9210; P < 0.00001; n = 6).
The potentiation began during infusion and was signifi-
cantly different ~60 min following infusion termination.
The mean maximal increase was 185% and persisted for
the duration of the 3-h recording period. Finally, intra-
hippocampal infusion of the 100 lmol/L concentration
produced a small and variable potentiation of the evoked
population spike (F41,205 = 1.97; P < 0.001; n = 6), with
the first significant increase at ~70 min postinfusion but
then returning to baseline, a second elevation occurred
2 h later and lasted 35 min, returning to baseline prior to
termination of recording. The maximal mean increase
occurred in the second period of potentiation and was
124% of baseline.
A two-way repeated measures ANOVA (concentra-
tion 9 time at 15 min preinfusion and 15, 110, and
180 min postinfusion) was used to assess between-group
effects of varying ISO concentrations. A significant inter-
action was found for the effects of varying concentrations
of ISO on the population spike amplitude
(F12,78 = 2.4123; P < 0.01). Post hoc analysis showed no
differences between groups in the 15-min period prior to
infusion; however, 15 min after the start of the infusion
of 0.1 lmol/L ISO, the population spike was depressed
compared to aCSF-infused control rats (see Fig. 2F). The
population spike amplitude in rats receiving 10 lmol/L
ISO was greater than that of rats receiving infusions of
either aCSF or any other ISO concentration. By 110 min
after the start of infusions, the spike amplitude of rats
infused with 10 lmol/L was still elevated, compared to all
other groups. At 180 min after infusion, the conclusion
of recording, the population spike amplitude of the
10 lmol/L group was greater than that of both the aCSF-
infused control rats and rats receiving an infusion of the
highest concentration of ISO (100 lmol/L).
Effects of intrahippocampal isoproterenol
on fEPSP slope–spike coupling in the
dentate gyrus
Input–output curves for the 10 levels of stimulation
were taken prior to baseline and at the termination of
recording (data not shown). The only significant change
(P < 0.05) occurred in the 10 lmol/L ISO group in
which there was a leftward shift in the input–output
relationship. This shift reflected the occurrence of larger
spikes postinfusion for the same stimulation levels more
than 3 h after infusion initiation, a result consistent
with the long-term increase in spike size with 10 lmol/
L ISO.
fEPSP slope/population spike correlations
In the majority of granule cells norepinephrine produces
a direct increase in membrane resistance that is mediated
by b-adrenoceptors (Lacaille and Schwartzkroin 1988).
We hypothesized that effective b-adrenoceptor activation
should increase the EPSP initiation of cell firing. Slope-
spike correlations were examined to address this question.
There were no significant correlations between the fEPSP
slope and spike size prior to infusion. Immediately after
infusion (postinfusion onset 15 min) there was a signifi-
cant positive correlation (r = 0.76, P < 0.05) in the aCSF
group that was not sustained (r = 0.52, ns at 180 min;
see Fig. 3A). In contrast, the 10 lmol/L ISO group exhib-
ited significant positive correlations between EPSP field
slope and population spike size at 110 min (r = 0.94,
P < 0.005; not shown) and 180 min (r = 0.80, P < 0.05)
postinfusion, the last two time points measured (see
Fig. 3B). No other group showed significant correlations
between fEPSP slope and population spike size post-
infusion.
Discussion
Effects of intrahippocampal ISO infusion on
the perforant path-dentate gyrus fEPSP
slope
The present pattern of results reveals a b-adrenoceptor-
induced long-term depression (LTD) of the perforant
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path-evoked fEPSP in the dentate gyrus at the lowest
level of receptor activation in this study (0.1 lmol/L).
A weaker level of depression was also seen with the next
higher dose (1 lmol/L). Winson and Dahl (1985) using
ISO iontophoresis in the mid-dendritic layer reported
depression of the perforant path fEPSP; however, fEPSP
depression occurred with all noradrenergic agents
applied.
In vitro exclusively lateral perforant path activation
paired with 1 lmol/L ISO produces a LTD of the fEPSP,
while medial perforant path pairing initiates long-term
potentiation at the same concentration (Dahl and Sarvey
1990). However, in this study, no attempt was made to
isolate lateral perforant path fibers. Stimulation coordi-
nates were selected for optimal generation of a medial
perforant path population spike. The stimulating elec-
trode placement was consistent across all concentrations.
Isoproterenol at the three higher concentrations had no
significant effect on the fEPSP.
The low-concentration b-adrenoceptor-elicited fEPSP
LTD seen here did not require sustained intermediate fre-
quency LTD stimulation as is typically needed to induce
LTD. In vitro b-adrenoceptor LTD in the lateral perforant
path has been shown to be both b-adrenoceptor and
NMDA-receptor dependent (Dahl and Sarvey 1989,
1990). It will be of interest to examine NMDA depen-
dence of low concentration ISO-induced LTD.
Effects of intrahippocampal ISO infusion on
the perforant path-dentate gyrus
population spike
The lowest concentration of ISO produced a transient
depression of the population spike. This did not temporally
follow fEPSP LTD at the same ISO concentration and the
two were not correlated. Winson and Dahl (1985) found a
depression of population spike amplitude with ISO ionto-
phoresis, which did not outlast the period of iontophoretic
current. Their population spike depression effect was b-
adrenoceptor receptor selective. With locus coeruleus elec-
trical stimulation they observed spike potentiation and
EPSP depression, although EPSPs had to be monitored in
the dendritic layer to detect the EPSP change.
The largest, and most enduring (>3 h) potentiation of
population spike amplitude seen here occurred at an
intermediate concentration of 10 lmol/L ISO. The high-
est concentration used did not produce long-term poten-
tiation and even the transient potentiation seen was
small.
All higher concentrations of ISO produced some degree
of b-adrenoceptor-mediated population spike potentiation
as has been reported in the majority of studies of norad-
renergic modulation of the perforant path input to den-
tate gyrus whether in vivo or in vitro. The long-lasting
potentiation effects here increased over time following
(A) (B)
Figure 3. The correlational fEPSP slope and population spike relationship before and after infusion of vehicle (aCSF) or 10 lmol/L ISO. No
relationship was found in any group during the preinfusion period (solid line in A and B for examples). (A) No changes were found in the fEPSP
slope and population spike correlation after infusion of aCSF at 180 min after infusion (dashed line). (B) Infusion of 10 lmol/L ISO produced a
positive correlation between fEPSP and population spike at 110 min (not shown; P < 0.005) and 180 min (P < 0.05; dashed line) after the
infusion.
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infusion. Late developing kinetics for norepinephrine-
induced long-term potentiation (NE-LTP) in dentate gyrus
has been reported previously with LC activation (Walling
and Harley 2004; Reid and Harley 2010). The mechanism
behind this gradually increasing potentiation profile is not
known. That such long-term potentiation is not simply a
generalized disinhibition effect is demonstrated by the
requirement that locus coeruleus activation must be paired
with perforant path activation for its occurrence (Reid and
Harley 2010). Transient disinhibition, however, is reliably
associated with locus coeruleus activation (Brown et al.
2005).
Increased EPSP-spike coupling
In the dentate gyrus, frequency-induced long-term poten-
tiation (LTP) frequently results in a leftward shift of the
EPSP slope-population spike (E-S) relationship (Bliss and
Lomo 1973; Kairiss et al. 1987). This leftward shift has
also been found in NE-LTP, induced by endogenous NE
release in awake rats (Walling and Harley 2004). In this
study, the optimal LTP-inducing concentration of ISO
(10 lmol/L) also produced a leftward shift in the E-S
relationship and this concentration was further associated
with a significant correlation between EPSP slope varia-
tion and spike variation. While the correlation effect may
be partially related to the larger range of spikes seen at
this concentration, both the significant correlation and
the leftward shift can be parsimoniously accounted for by
a b-adrenoceptor-mediated increase in granule cell mem-
brane resistance (Lacaille and Schwartzkroin 1988).
b-adrenoceptor effects as related to locus
coeruleus activation
The present results suggest that the b-adrenoceptor effects
on long-term plasticity of either the fEPSP or the popula-
tion spike are not linearly related to dose. Intermediate,
rather than maximal, doses appear to provide the clearest
effects. This is consistent with a reported inverted
U-curve for norepinephrine-associated arousal on neuro-
nal activity and/or behavior and may provide an under-
pinning of such effects in the dentate gyrus. In previous
in vivo work all of the plasticity effects of locus coeruleus
activation on the dentate gyrus-perforant path-evoked
potential, whether in urethane-anesthetized (Harley and
Milway 1986; Harley et al. 1989) or awake rats (Kitchigi-
na et al. 1997; Walling and Harley 2004) could be
blocked by the b-adrenoceptor antagonist propranolol.
Future studies will be required to delineate the substrates
of the concentration effects observed. Varying
concentrations of ISO may recruit differing proportions of
b-adrenoceptor subtypes and the predominant localization
of the b-adrenoceptor subtypes recruited may also differ.
Higher concentrations may also be less selective for
b-adrenoceptors. The main point of interest of the present
experiments is that enduring, and differing, plasticity
effects are recruited by different levels and/or patterns of
b-adrenoceptor activation. The local modulation of norepi-
nephrine levels is likely to play a critical role in recruitment
of plasticity, at least within the dentate gyrus.
Naturalistic modulation of dentate gyrus
plasticity
The present patterns of results are consistent with inde-
pendent b-adrenoceptor modulation of both synaptic
input and cell excitability. Previous naturalistic investiga-
tions of novelty exploration, which activates the locus
coeruleus (Vankov et al. 1995), together with monitoring
of the perforant path-evoked potential, have revealed both
an increase in cell excitability (Kitchigina et al. 1997) and
a decrease in synaptic input (Moser 1996). A b-adreno-
ceptor antagonist prevented the increase in cell excitability
(Kitchigina et al. 1997). The depression of synaptic input
was not assessed pharmacologically (Moser 1996). Both
forms of plasticity can be input selective (see for example
Frick and Johnston 2005). Selective dendritic excitability
changes have been proposed as another potential under-
pinning of learning and memory circuit changes (Frick
and Johnston 2005; Reid and Harley 2010).
This study suggests that differences in norepinephrine
release levels will recruit varying changes in granule cell
information processing through b-adrenoceptor modula-
tion, which has an optimal window for enduring plasticity
effects. These in vivo infusion experiments also reveal a
novel b-adrenoceptor-mediated LTD effect on glutamater-
gic synaptic signaling in dentate gyrus.
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